Literature DB >> 10155318

The added costs of depression to medical care.

K Franco1, M Tamburino, N Campbell, J Zrull, C Evans, D Bronson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 10155318     DOI： 10.2165/00019053-199507040-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  87 in total

1.  The adequacy of treating depression.

Authors:  M B Keller; P W Lavori
Journal:  J Nerv Ment Dis       Date:  1988-08       Impact factor: 2.254

Review 2.  Perspectives on the relationship between cardiovascular disease and affective disorder.

Authors:  G W Dalack; S P Roose
Journal:  J Clin Psychiatry       Date:  1990-07       Impact factor: 4.384

3.  Disability and depression among high utilizers of health care. A longitudinal analysis.

Authors:  M Von Korff; J Ormel; W Katon; E H Lin
Journal:  Arch Gen Psychiatry       Date:  1992-02

4.  Do different subtypes of hospitalized depressives have different long-term outcomes?

Authors:  C F Duggan; A S Lee; R M Murray
Journal:  Arch Gen Psychiatry       Date:  1991-04

Review 5.  Depression and somatization: a review. Part II.

Authors:  W Katon; A Kleinman; G Rosen
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

Review 6.  Depression in the medically ill: an overview.

Authors:  G Rodin; K Voshart
Journal:  Am J Psychiatry       Date:  1986-06       Impact factor: 18.112

7.  The 'offset effect' of mental health treatment on ambulatory medical care utilization and charges. Month-by-month and grouped-month analyses of a five-year study.

Authors:  J F Borus; M C Olendzki; L Kessler; B J Burns; U C Brandt; C A Broverman; P R Henderson
Journal:  Arch Gen Psychiatry       Date:  1985-06

8.  Depression and somatization: a review. Part I.

Authors:  W Katon; A Kleinman; G Rosen
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

9.  Psychiatric aspects of diabetes mellitus.

Authors:  D H Surridge; D L Erdahl; J S Lawson; M W Donald; T N Monga; C E Bird; F J Letemendia
Journal:  Br J Psychiatry       Date:  1984-09       Impact factor: 9.319

10.  Screening women in family practice settings: association between depression and smoking cigarettes.

Authors:  M B Tamburrino; D J Lynch; R W Nagel; N Stadler; T Pauling
Journal:  Fam Pract Res J       Date:  1994-12
View more
  7 in total

1.  Current issues in the economics of depression management.

Authors:  D Thompson; E Richardson
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

Review 2.  Cost-of-illness studies. Useful for health policy?

Authors:  M A Koopmanschap
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

3.  The treatment of anxiety disorders in a primary care HMO setting.

Authors:  D Price; A Beck; C Nimmer; S Bensen
Journal:  Psychiatr Q       Date:  2000

Review 4.  Fluoxetine. A pharmacoeconomic review of its use in depression.

Authors:  M I Wilde; P Benfield
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

Review 5.  The need for an iterative process for assessing economic outcomes associated with SSRIs.

Authors:  T L Skaer; D A Sclar; L M Robison; R S Galin
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

6.  Diagnosis of depression and use of antidepressant pharmacotherapy among adults in the United States: does a disparity persist by ethnicity/race?

Authors:  David A Sclar; Linda M Robison; Jennifer M Schmidt; Kurt A Bowen; Leigh V Castillo; Ambartsum M Oganov
Journal:  Clin Drug Investig       Date:  2012-02-01       Impact factor: 2.859

Review 7.  Economic considerations in the prescribing of third-generation antidepressants.

Authors:  Stuart Montgomery; John J Doyle; Lee Stern; Christopher R McBurney
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.